Also known as آسٹیوپوروسس مینجمنٹ
Cardiologist
M.B.B.S., M.Phil (Clinical Pharmacology), Dip. Diabetes, Ph.D Scholar (Clinical Pharmacology), M.D (Cardiology)
Cardiologist
M.B.B.S., M.Phil (Clinical Pharmacology), Dip. Diabetes, Ph.D Scholar (Clinical Pharmacology), M.D (Cardiology)
Endocrinologist
MBBS (Gold Medalist), FCPS (Internal Medicine), F.C.P.S. (Endocrinology), Fellowship in Diabetes, Endocrine and Metabolism(AKUH), SCE Endocrine & Diabetes (UK)
Endocrinologist
MBBS (Gold Medalist), FCPS (Internal Medicine), F.C.P.S. (Endocrinology), Fellowship in Diabetes, Endocrine and Metabolism(AKUH), SCE Endocrine & Diabetes (UK)
Gastroenterologist
MBBS, FRCP, FEBGH, MRCP, CCST
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Diabetologist
M.B.B.S, MRCP (UK), MRCP (London), Specialty Certificate in Endocrinology and Diabetes
Diabetologist
M.B.B.S, MRCP (UK), MRCP (London), Specialty Certificate in Endocrinology and Diabetes
Family Physician
MBBS, DFM (Family Medicine), MCPS (Family Medicine), MRCGP (International), Diploma in Diabetes
Family Physician
MBBS, DFM (Family Medicine), MCPS (Family Medicine), MRCGP (International), Diploma in Diabetes
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Diabetologist
MBBS, Diploma in Diabetology, MSc (Diabetes & Endocrinology)
Gastroenterologist
M.B.B.S, F.C.P.S (Gastroenterology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures